Prexton Therapeutics' Seed VC Round

Prexton Therapeutics raised a round of funding on July 30, 2012. Investors include Merck Ventures.

Prexton Therapeutics is a biopharmaceutical company which applies a new scientific approach that fully integrates molecular, behavioral and chemistry technologies to address Parkinson's disease and ot…

Articles about Prexton Therapeutics' Seed VC Round: